SCHEMBL3416748

SCHEMBL3416748

COc1ccc(-c2cccc(C(=O)O)c2)cc1CNC(=O)c1ccc(OC(C)C)cc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 4/20 0.64
PPARA Q07869 4/20 0.64
PPARG P37231 4/20 0.64
WDR5 P61964 1/20 0.46
ACLY P53396 1/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HTT P42858 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
ROCK2 O75116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3415535 0.94 PPARD (0.55) PPARDPPARAPPARGWDR5ACLY
SCHEMBL3414385 0.91 PPARD (0.55) PPARDPPARAPPARGWDR5ACLY
SCHEMBL3416134 0.90 PPARD (0.59) PPARDPPARAPPARG
SCHEMBL3416718 0.89 PPARD (0.48) PPARDPPARAPPARGACLYHTT
SCHEMBL3413789 0.89 PPARD (0.49) PPARDPPARAPPARGWDR5NPC1
SCHEMBL3410372 0.88 PPARD (0.51) PPARDPPARAPPARGHTTALDH1A1
SCHEMBL3414230 0.88 PPARA (0.63) PPARDPPARAPPARGACLYHTT
SCHEMBL3414075 0.88 PPARD (0.61) PPARDPPARAPPARGACLYKMT2A
SCHEMBL13433435 0.88 PPARA (0.48) PPARDPPARAPPARGHTTALDH1A1
SCHEMBL3417095 0.87 PPARD (0.51) PPARDPPARAPPARGWDR5ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-10-28 US disclosed
EP-1394147-A1 CARBOXYLIC ACID DERIVATIVE AND MEDICINE COMPRISING SALT OR ESTER OF THE SAME Eisai Co., Ltd. (JP) 2004-03-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same GPR119, NR3C1, INSR PPARD 689/4885PPARA 130/4885PPARG 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.